LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

Kodu・Aktsiate loetelu・Pulse Biosciences Inc

Pulse Biosciences Inc

Suletud

SektorTervishoid

13.04 0.15

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

12.97

Max

13.26

Põhinäitajad
By Trading Economics
Sissetulek	-217K -19M
Müük	86K 86K
Aktsiakasum	-0.29
Kasumimarginaal	-22,540.698
Töötajad	75
EBITDA	-228K -19M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+69.1% upside

Turustatistika
By TradingEconomics
Turukapital	-179M 958M
Eelmine avamishind	12.89
Eelmine sulgemishind	13.04

Uudiste sentiment

By Acuity

50%

181 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

16.59 / 17.17 Toetus ja vastupanu

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. nov 2025, 21:54 UTC

Omandamised, ülevõtmised, äriostud

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175 Million

24. nov 2025, 18:26 UTC

Suurimad hinnamuutused turgudel

Tegna Shares Fall After Trump Blasts Proposal to Lift Broadcast Ownership Cap

24. nov 2025, 23:49 UTC

Market Talk

Nikkei May Rise After Tech Recovery on Wall Street -- Market Talk

24. nov 2025, 23:08 UTC

Market Talk

More Losses Ahead for Steel & Tube, Says New Bear -- Market Talk

24. nov 2025, 23:08 UTC

Market Talk

Global Equities Roundup: Market Talk

24. nov 2025, 22:56 UTC

Market Talk

Tulu

Alimentation Couche-Tard U.S. Sales Gain Momentum -- Market Talk

24. nov 2025, 22:47 UTC

Market Talk

Kiwi Property Can Keep Growing Its Dividend -- Market Talk

24. nov 2025, 22:36 UTC

Market Talk

Tulu

Kiwi Property's 1H Result Cements Bull's Confidence in Outlook -- Market Talk

24. nov 2025, 22:32 UTC

Tulu

Webco Industries 1Q EPS $6.79 >WEBC

24. nov 2025, 22:07 UTC

Tulu

Couche-Tard 2Q Canada Same-Store Merchandise Revenues Up 5.4% >ATD.T

24. nov 2025, 22:07 UTC

Tulu

Couche-Tard 2Q U.S. Same-Store Merchandise Revenues Up 1.2% >ATD.T

24. nov 2025, 22:06 UTC

Tulu

Couche-Tard 2Q Adj EPS 78c >ATD.T

24. nov 2025, 22:06 UTC

Tulu

Couche-Tard 2Q Rev $17.9B >ATD.T

24. nov 2025, 22:06 UTC

Tulu

Couche-Tard 2Q EPS 79c >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q Rev $17.9B >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q Net $740.6M >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q Adj EPS 78c >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q EPS 79c >ATD.T

24. nov 2025, 21:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

24. nov 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

24. nov 2025, 21:44 UTC

Market Talk

Canada Close to MOU With Alberta About New Possible Pipeline -- Market Talk

24. nov 2025, 21:39 UTC

Omandamised, ülevõtmised, äriostud

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175M

24. nov 2025, 20:42 UTC

Market Talk

Oil Futures Snap Three-Session Losing Streak -- Market Talk

24. nov 2025, 20:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

24. nov 2025, 19:56 UTC

Omandamised, ülevõtmised, äriostud

Nvidia Says It's Not Enron in Private Memo Refuting Accounting Questions -- Barrons.com

24. nov 2025, 18:26 UTC

Market Talk

Crude Futures Move Higher in Choppy Trade -- Market Talk

24. nov 2025, 17:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

24. nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

24. nov 2025, 17:09 UTC

Market Talk

Brent Could Drop to the $30s Without Production Cuts, JPM Says -- Market Talk

24. nov 2025, 16:52 UTC

Omandamised, ülevõtmised, äriostud

Strategy Silent on Bitcoin Holdings. Why It's a Big Deal for the Stock and Cryptos. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

69.1% tõus

12 kuu keskmine prognoos

Keskmine 22 USD 69.1%

Kõrge 22 USD

Madal 22 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Pulse Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

16.59 / 17.17Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

181 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.